Anti-rejection and immune therapy are associated with risk of death from infection and malignancy
What is it about?
Immune therapy is being advertised for many different medical problems and prescribed by neurologists, nephrologists, dermatologists, hematologists, gastroenterologists. Successful transplant recipients have been evaluated for heart disease prior to undergoing transplant. In a study designed to determine whether the risk for cardiovascular disease could be reduced by certain vitamins (B12 and folic acid), we observed that the majority of deaths
Why is it important?
As immune therapies increase for various disease, we must be aware of the greater risk on infection and malignancy than cardiovascular disease in populations presumed to be at low risk for heart attack and stroke. Screening for malignancy and attention to vaccination in patients under immune therapy needs to be stressed.
The following have contributed to this page: Larry Weinrauch